Methylphenidate Multiphasic Release Tablet: Bioequivalence Assessment between Two Formulations Administered under Fasting and Fed Conditions

Methylphenidate hydrochloride is used to treat children, adolescents, and adults with attention deficit/hyperactivity disorder (ADHD). Multiphasic release formulation has been used to control drug levels, mainly during children’s school period. This study aimed to evaluate the bioequivalence between...

Descripción completa

Detalles Bibliográficos
Autores principales: Davanço, Marcelo Gomes, Meulman, Jessica, da Silva, Thalita Martins, Costa, Fernando, Bellorio, Karini Bruno, Mundim, Iram Moreira, Sampaio, Ana Carolina Costa, Teixeira, Leonardo de Souza, Vespasiano, Celso Francisco Pimentel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304685/
https://www.ncbi.nlm.nih.gov/pubmed/37376185
http://dx.doi.org/10.3390/pharmaceutics15061737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304685/
https://www.ncbi.nlm.nih.gov/pubmed/37376185
http://dx.doi.org/10.3390/pharmaceutics15061737

Ejemplares similares